News and Opinions - World Stem Cell Summit

Scientists create a cell that precludes malignant growth

by admin | Jul 18, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Helsinki – Phys.org – Cell therapies could help in the treatment of hereditary diseases, myocardial infarction and hundreds of other diseases. For many blood diseases, new cells can already be transplanted into human patients, and diabetes...

A patch fitted with stem cells helps repair damaged spinal cords

by admin | Jul 17, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Clara Rodriguez Fernandez – Advanced Science News – Scientists have taken a step closer toward a treatment to repair damaged spinal cord tissue with a wireless patch that delivers electrical pulses to stem cells. The device could overcome some major...

Prime Editing Corrects Cystic Fibrosis Mutation

by admin | Jul 16, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Gorm Pamgren – CRISPR Medicine News – Researchers have refined prime editing (PE) to correct the cystic fibrosis (CF) related gene CFTR. Results demonstrated improved efficiency and minimal off-target effects in correcting the F508del mutation in human...

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by admin | Jul 15, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Science Daily News – CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response. Source: Stanford Medicine. Click Here to read the...

CAR T cell therapy for pediatric brain cancer warrants further study

by admin | Jul 12, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Baylor College of Medicine – Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using...

J.P. Morgan’s private financing arm closes inaugural 0M-plus biotech fund

J.P. Morgan’s private financing arm closes inaugural $500M-plus biotech fund

by admin | Jul 11, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Gabrielle Masson – Fierce Biothech – J.P. Morgan Private Capital has closed an inaugural life sciences fund of more than $500 million, cash that will go toward a wide range of private biotechs and build value for existing portfolio companies. Dubbed the...